
Thursday, July 21, 2022 11:02:28 AM
Value: “During this phase, we expect to work closely with early access customers to demonstrate a unique value proposition for our proteomics product platform”
We could begin to hear positive comments about the platform any day.
my posts are always theory and not financial advice

Liked By
Spread the love. Be the first to like this post!
Recent NAUT News
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 • GlobeNewswire Inc. • 01/26/2023 01:00:00 PM
- Nautilus Biotechnology Expands to San Diego • GlobeNewswire Inc. • 01/26/2023 12:45:00 PM
- Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
- Nautilus Biotechnology Launches “First Access Challenge” • GlobeNewswire Inc. • 11/16/2022 01:00:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/01/2022 08:10:29 PM
- Amended Current Report Filing (8-k/a) • Edgar (US Regulatory) • 11/01/2022 10:10:26 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/01/2022 10:08:15 AM
- Nautilus Biotechnology Reports Third Quarter 2022 Financial Results • GlobeNewswire Inc. • 11/01/2022 10:05:00 AM
- Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 • GlobeNewswire Inc. • 10/05/2022 12:00:00 PM
- Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit • GlobeNewswire Inc. • 09/23/2022 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 09/19/2022 09:51:02 PM
- Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board • GlobeNewswire Inc. • 09/01/2022 12:00:00 PM
- Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference • GlobeNewswire Inc. • 08/30/2022 12:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/22/2022 11:41:33 PM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 08/09/2022 08:23:22 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 08/09/2022 10:08:45 AM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 08/08/2022 11:49:38 PM
- Nautilus Biotechnolgy (NAUT) Gets a Hold Rating from Goldman Sachs • TipRanks • 08/03/2022 04:45:09 PM
- Nautilus Biotechnolgy (NAUT) Gets a Hold Rating from Morgan Stanley • TipRanks • 08/03/2022 04:44:51 PM
- Post-effective Amendment to Registration Statement (pos Am) • Edgar (US Regulatory) • 08/02/2022 08:28:47 PM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 08/02/2022 08:25:46 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 08/02/2022 08:05:41 PM
- Nautilus Biotechnology Reports Second Quarter 2022 Financial Results • GlobeNewswire Inc. • 08/02/2022 10:48:06 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/02/2022 10:00:58 AM
- Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development • GlobeNewswire Inc. • 08/01/2022 08:05:00 PM
TNRG Signs Reg A Offering Agreement • TNRG • Feb 3, 2023 10:30 AM
Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM
Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • GSHRF • Feb 2, 2023 9:58 AM
Hempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products • HPCO • Feb 2, 2023 9:30 AM
Kona Gold Beverage, Inc Announces Record Revenue Month in January Eclipsing Half a Million Dollars for the First Time • KGKG • Feb 2, 2023 9:00 AM
BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm • BLFE • Feb 2, 2023 8:32 AM